ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Aceso Life Science Group Ltd. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-11.76%
EBIT Growth (5y)
-1.95%
EBIT to Interest (avg)
-1.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.98
Tax Ratio
1.07%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.26%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.07
EV to EBIT
0.50
EV to EBITDA
0.65
EV to Capital Employed
0.44
EV to Sales
-0.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
87.44%
ROE (Latest)
-3375.00%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at HKD -176 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 74%
-12What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at HKD -263 MM
ROCE(HY)
Lowest at -191.85%
DEBT-EQUITY RATIO
(HY)
Highest at 17,283.33 %
RAW MATERIAL COST(Y)
Grown by 66.69% (YoY
CASH AND EQV(HY)
Lowest at HKD 227 MM
NET SALES(Q)
Lowest at HKD 86 MM
PRE-TAX PROFIT(Q)
Lowest at HKD -222 MM
EPS(Q)
Lowest at HKD -0.11
Here's what is working for Aceso Life Science Group Ltd.
Net Profit
Higher at HKD -176 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (HKD MM)
Inventory Turnover Ratio
Highest at 74%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
At HKD 24 MM has Grown at 26.32%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Aceso Life Science Group Ltd.
Debt-Equity Ratio
Highest at 17,283.33 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Cash Flow
Lowest at HKD -263 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Net Sales
Lowest at HKD 86 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Net Sales
Fallen at -38.13%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Pre-Tax Profit
Lowest at HKD -222 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
EPS
Lowest at HKD -0.11
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
Cash and Eqv
Lowest at HKD 227 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 66.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
